World's Best Scientists 2026 revealed!
Journal de Mycologie Medicale
H-index 16

Journal de Mycologie Medicale

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Microbiology 138 32 53 15

Additional Metrics

Number of Best Scientists*: 53
Documents by Best Scientists*: 73
Top 100 Ranked Scientists*: 1
SCIMAGO H-index: 46
SCIMAGO SJR: 0.429
Impact Factor: 1.8

Overview

Top Research Topics at Journal De Mycologie Medicale?

The journal investigates studies in Microbiology, Gynecology, Candida albicans, Molecular biology and Mycosis. In the Microbiology research discussed, Fungi imperfecti, Fluconazole, Amphotericin B, Corpus albicans and Minimum inhibitory concentration are all tackled. Journal De Mycologie Medicale links adjacent topics like Amphotericin B with Voriconazole.

Most of the works presented in it deals with Mycosis but it intersects with the subject of Pathology.

  • Microbiology (21.67%)
  • Gynecology (11.02%)
  • Candida albicans (9.85%)

What are the most cited papers published in the journal?

  • Identification of Malassezia species : A practical approach (276 citations)
  • Antifungal efficacy of thymol, carvacrol, eugenol and menthol as alternative agents to control the growth of food-relevant fungi. (156 citations)
  • Infections caused by the Oomycetous pathogen Pythium insidiosum (148 citations)

Research areas of the most cited articles at Journal De Mycologie Medicale:

The published papers tackle a plethora of topics, such as Microbiology, Candida albicans, Antimicrobial, Minimum inhibitory concentration and Essential oil. The studies on Candida albicans discussed at the most cited papers can also contribute to research in the domains of Internal medicine, Immunology and Yeast. The works on Minimum inhibitory concentration tackled in the journal articles bring together disciplines like Agar diffusion test, Amphotericin B and Food science.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Surgery
  • Bacteria

The previous edition focused in particular on these issues:

The journal aims to foster the development of research in Itraconazole, Dermatology, Amphotericin B, Lesion and Renal transplant. Journal De Mycologie Medicale focused on Itraconazole research conducted under the discipline of Microbiology. Journal De Mycologie Medicale holds forums on Dermatology that merges themes from other disciplines such as Voriconazole, Hyaline and Chronic granulomatous disease.

In Journal De Mycologie Medicale, Tertiary care hospital, Candida spp and Natamycin are investigated in conjunction with one another to address concerns in Amphotericin B research. The concepts on Lesion presented in the journal can also apply to other research fields, including Opportunistic infection, Talaromyces marneffei and Scalp.

The most cited articles from the last journal are:

  • Title of Paper: First case of subcutaneous infection by Talaromyces marneffei in a renal transplant recipient from India and review of literature. (0 citations)
  • First case of Tropicoporus tropicalis keratitis in an immunocompetent host from India and review of the literature. (0 citations)
  • EMERGING ISSUE OF FLUCONAZOLE-RESISTANT CANDIDEMIA IN A TERTIARY CARE HOSPITAL OF SOUTHERN ITALY: TIME FOR ANTIFUNGAL STEWARDSHIP PROGRAM (0 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal De Mycologie Medicale (based on the number of publications) are:

  • Fattouma Makni (41 papers) absent at the last edition,
  • Hayet Sellami (40 papers) absent at the last edition,
  • Alireza Khosravi (37 papers) absent at the last edition,
  • Laurence Millon (35 papers) absent at the last edition,
  • Sourour Neji (35 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal De Mycologie Medicale (based on the number of publications) are:

  • Pasteur Institute (81 papers) absent at the last edition,
  • University of Tehran (50 papers) absent at the last edition,
  • Tehran University of Medical Sciences (40 papers) absent at the last edition,
  • Necker-Enfants Malades Hospital (31 papers) absent at the last edition,
  • Cheikh Anta Diop University (30 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2022 edition, 0.00% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 0.00% were posted by at least one author from the top 10 institutions publishing in the journal. Another 20.00% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 40.00% of all publications and 40.00% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Invasive fungal diseases during COVID-19: We should be prepared.

    J.-P. Gangneux;M.-E. Bougnoux;E. Dannaoui;M. Cornet

    (2020)
    347 Citations
  • Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis

    H. Jafri;I. Ahmad

    (2020)
    114 Citations
  • Trichophyton indotineae, from epidemiology to therapeutic.

    (2023)
    45 Citations
  • Potent in vitro activity of curcumin and quercetin co-encapsulated in nanovesicles without hyaluronan against Aspergillus and Candida isolates

    Zaynab Sadeghi-Ghadi;Afsane Vaezi;Fatemeh Ahangarkani;Macit Ilkit

    (2020)
    39 Citations
  • Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species.

    (2022)
    34 Citations
  • Cryptococcosis in HIV-AIDS patients from Southern Brazil: Still a major problem

    L.B. da Silva;D. Bock;G.B. Klafke;K.O. Sanchotene

    (2020)
    30 Citations
  • Candida africana vulvovaginitis: Prevalence and geographical distribution

    H. Fakhim;A. Vaezi;J. Javidnia;E. Nasri

    (2020)
    24 Citations
  • Ketoconazole-loaded poly-(lactic acid) nanoparticles: Characterization and improvement of antifungal efficacy in vitro against Candida and dermatophytes.

    E.H. Endo;R.Y. Makimori;M.V.P. Companhoni;T. Ueda-Nakamura

    (2020)
    22 Citations
  • Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.

    Z. Salehi;N. Fatahi;M. Taran;A. Izadi

    (2020)
    22 Citations
  • Earliest case of Candida auris infection imported in 2007 in Europe from India prior to the 2009 description in Japan.

    Marie Desnos-Ollivier;Arnaud Fekkar;Stéphane Bretagne

    (2021)
    22 Citations

Best Scientists Contributing to This Journal

Recently Published Articles